Intervention

Carbamazepine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 8 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials8

Recruiting0

Common conditions16

Lead sponsors shown7

Clinical trials

8 shown

A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female ParticipantsNCT06547164 · 2024-08-27

COMPLETED

A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy ParticipantsNCT06348888 · 2024-04-10

COMPLETED

Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult ParticipantsNCT05581823 · 2022-10-19

COMPLETED

Pharmacovigilance in Gerontopsychiatric PatientsNCT02374567 · 2015-01-01

TERMINATED

Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 PatientsNCT04371575 · 2012-09-01

COMPLETED

Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy PainNCT01089855 · 2009-12-01

COMPLETED

Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial AsthmaNCT00153296 · 2004-08-01

COMPLETED

Antiepileptic Drug Carbamazepine in Treatment of Bronchial AsthmaNCT00207428 · 1999-08-01

COMPLETED

Common conditions

Bronchial Asthma2 Advanced Non-small Cell Lung Cancer1 Anxiety Disorders1 Dementia1 Depression1 EGFR Mutation1 Healthy Participants1 Healthy Volunteers1 HER2 Mutation1 Multiple Sclerosis1 Neuropathic Pain1 Pain, Neuropathic1 Parkinson Disease1 Psychosomatic Disorders1 Schizophrenia1 Trigeminal Neuralgia1

Leading sponsors

Centre of Chinese Medicine, Georgia 2 AstraZeneca 1 Bayer 1 Cerevel Therapeutics, LLC 1 Hannover Medical School 1 Novartis 1 Stine Maarbjerg, MD PhD 1

Trial status mix

COMPLETED7

TERMINATED1

Phase mix

PHASE13

PHASE43

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.